Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients.
- Resource Type
- Editorial & Opinion
- Authors
- Grau S; Department of Pharmacy, Hospital del Mar, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.; Vela JM; Welab Barcelona, Parc Científic de Barcelona, Barcelona 08028, Spain.; Gurt A; CAP Vila Olímpica, Parc Sanitari Pere Virgili, Barcelona, Spain.; Barceló-Vidal J; Department of Pharmacy, Hospital del Mar, 08003 Barcelona, Spain.; Ojeda F; Rheumatology Service, Hospital del Mar, Barcelona, Spain.; López I; IMIM (Hospital Del Mar Medical Research Institute), PRBB, Barcelona, Spain.; Gómez-García L; Health Research Institute of Santiago de Compostela (IDIS), Drug Screening and Pharmacogenomics Platform/BioFarma Research Group, CIMUS Research Center, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Loza MI; Health Research Institute of Santiago de Compostela (IDIS), Drug Screening and Pharmacogenomics Platform/BioFarma Research Group, CIMUS Research Center, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Martín-García E; IMIM (Hospital Del Mar Medical Research Institute), PRBB, Barcelona, Spain; Laboratory of Neuropharmacology-Neurophar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Departament de Psicobiologia i Metodologia de les Ciències de la Salut, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Maldonado R; IMIM (Hospital Del Mar Medical Research Institute), PRBB, Barcelona, Spain; Laboratory of Neuropharmacology-Neurophar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain. Electronic address: rafael.maldonado@upf.edu.; Monfort J; Rheumatology Service, Hospital del Mar, Barcelona, Spain; IMIM (Hospital Del Mar Medical Research Institute), PRBB, Barcelona, Spain.
- Source
- Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE
- Subject
- Language
- English
Competing Interests: Declaration of Competing Interest The authors declare that they have no competing interests.